{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9BYF1",
      "entity_text" : "ACE-2",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-1198" ],
      "Organ" : [ "uberon:UBERON:0002049" ],
      "CellType" : [ "cl:CL:0000125" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Accordingly, during the still ongoing COVID-19 outbreak, several concerns have been raised about the safety of ACE inhibitors (ACE-Is) and angiotensin II receptor blockers (ARBs), both routinely used for the treatment of systemic hypertension, because of their well-known modulatory effects on the ACE-2 expression.",
  "reading_complete" : "2020-08-05T19:12:26Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T19:11:48Z",
  "trigger" : "expression",
  "evidence" : [ "ACE-2 expression" ],
  "pmc_id" : "7347486",
  "score" : 0
}